Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

11.08
Delayed Data
As of Oct 20
 -0.26 / -2.29%
Today’s Change
5.36
Today|||52-Week Range
13.40
+26.05%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close11.34
Today’s open11.43
Day’s range11.08 - 11.43
Volume1,791,018
Average volume (3 months)3,723,250
Market cap$2.1B
Dividend yield--
Data as of 4:14pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-10.77%
Earnings growth (this year)-37.19%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.41%
P/E ratioNM
Price/Sales9.06
Price/Book161.85

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.81+2.18%
MYOKMyoKardia Inc-0.90-2.38%
CBMCambrex Corp0.000.00%
TBPHTheravance Biopharma...-0.33-1.01%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$150.9M
Annual profit (last year)-$116.8M
Net profit margin-77.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts